Open Access iconOpen Access

ARTICLE

crossmark

Expression and function of long non-coding RNA DLX6-AS1 in endometrial cancer

WEI SHI1,2,3,#, JIANXIA LIN1,2,3,#, RONG JIN1,2,3, XIANJING XIE1,2,3, YAN LIANG1,2,3,*

1 Department of Gynecologic Oncology, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, China
2 Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, 200030, China
3 Shanghai Municipal Key Clinical Specialty, Shanghai, 200030, China

* Corresponding Author: YAN LIANG. Email: email
# These authors contributed to the work equally

BIOCELL 2023, 47(4), 869-877. https://doi.org/10.32604/biocell.2023.026037

Abstract

Background: LncRNA DLX6-AS1 has been uncovered to exert effects on various cancers. Nevertheless, the impacts of DLX6-AS1 on endometrial cancer (EC) development remained obscure. The study explored the influence of DLX6-AS1 on EC progression via the microRNA (miR)-374a-3p/zinc-finger protein (ZFX) axis.Methods: EC cell lines were collected and DLX6-AS1, miR-374a-3p, and ZFX levels in EC cell lines were detected. The EC cells were transfected with DLX6-AS1, miR-374a-3p, and ZFX constructs to examine the biological functions of EC cells. The xenograft model was established for detecting tumor growth. Rescue experiments were conducted to verify the interaction of DLX6-AS1, miR-374a-3p, and ZFX in EC cells.Results: DLX6-AS1 and ZFX levels were elevated, while miR-374a-3p exhibited a reduced level in EC cells. Silencing DLX6-AS1 and elevated miR-374a-3p expressions repressed the biological activities of EC cells. Reduced DLX6-AS1 repressed tumor development. MiR-374a-3p silencing reversed the impacts of DLX6-AS1 silencing, while ZFX overexpression abrogated the impacts of miR-374a-3p elevation on EC cell growth. Mechanically, DLX6-AS1 was found to bind to miR-374a-3p, and miR-374a-3p targeted ZFX.Conclusion: DLX6-AS1 depletion restricts the malignant phenotype of EC cells. The study might provide novel therapeutic biomarkers for EC treatment.

Graphical Abstract

Expression and function of long non-coding RNA DLX6-AS1 in endometrial cancer

Keywords


Cite This Article

APA Style
SHI, W., LIN, J., JIN, R., XIE, X., LIANG, Y. (2023). Expression and function of long non-coding RNA DLX6-AS1 in endometrial cancer. BIOCELL, 47(4), 869-877. https://doi.org/10.32604/biocell.2023.026037
Vancouver Style
SHI W, LIN J, JIN R, XIE X, LIANG Y. Expression and function of long non-coding RNA DLX6-AS1 in endometrial cancer. BIOCELL . 2023;47(4):869-877 https://doi.org/10.32604/biocell.2023.026037
IEEE Style
W. SHI, J. LIN, R. JIN, X. XIE, and Y. LIANG "Expression and function of long non-coding RNA DLX6-AS1 in endometrial cancer," BIOCELL , vol. 47, no. 4, pp. 869-877. 2023. https://doi.org/10.32604/biocell.2023.026037



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1356

    View

  • 392

    Download

  • 0

    Like

Share Link